Companies: 48,687 Total Market Cap: 127170828859578.36

Alcon

NYSE: ALC
Healthcare Medical Instruments & Supplies
Rank #428
Market Cap 48.62 B
Volume 1.71 M
Price 98.31
Change (%) 2.23%
Country or region Switzerland Switzerland

Alcon's latest marketcap:

48.62 B

As of May 4, 2025, Alcon's market capitalization has reached $48.62 B. According to our data, Alcon is the 428th most valuable company globally by market capitalization. Market capitalization, commonly referred to as market cap, represents the total market value of all outstanding shares of a publicly traded company and is often used as a measure of company value.

Market Cap 48.62 B
Revenue (ttm) 9.91 B
Net Income (ttm) 1.02 B
Shares Out 494.62 M
EPS (ttm) 2.05
Forward PE 30.11
Ex-Dividend Date May 13, 2025
Earnings Date May 12, 2025
Market Cap Chart
Data Updated: May 4, 2025

Alcon's yearly market capitalization.

Alcon has seen its market value grow from $33.05 B to $47.17 B since 2020, representing a total increase of 42.74% and an annual compound growth rate (CAGR) of 8.57%.
Date Market Cap Change (%)
April 28, 2025 $47.17 B 12.49%
December 30, 2024 $41.93 B 9.07%
December 29, 2023 $38.45 B 14.43%
December 30, 2022 $33.60 B -22.39%
December 30, 2021 $43.29 B 30.98%
December 30, 2020 $33.05 B

Company Profile

About Alcon Inc.

Alcon Inc. is a global leader in eye care, specializing in the research, development, manufacturing, and distribution of innovative products for surgical and vision care needs. Headquartered in Geneva, Switzerland, the company has been dedicated to improving eye health since its founding in 1945.

Business Segments

Alcon operates through two primary segments:

  • Surgical: Focuses on advanced equipment, diagnostics, and implantables for eye surgeries.
  • Vision Care: Provides contact lenses and ocular health products for everyday eye care.

Key Products & Solutions

Surgical Segment

  • Cataract Solutions: Includes the Centurion vision system, LenSx laser system, Verion digital marker, and a range of intraocular lenses (IOLs).
  • Vitreoretinal Products: Features the Constellation vision system, vitrectomy probes, and precision surgical instruments.
  • Refractive Surgery: Offers WaveLight and Contoura Vision technologies for LASIK procedures.

Vision Care Segment

  • Contact Lenses: Daily disposable, reusable, and color-enhancing options.
  • Ocular Health: Products for dry eye, allergies, glaucoma, and contact lens care, as well as vitamins and redness relievers.

Company Background

Originally established as Alcon Universal S.A., the company rebranded as Alcon Inc. in 2001. With decades of expertise, Alcon continues to drive innovation in eye care, helping millions of people worldwide achieve better vision.

Frequently Asked Questions

As of May 4, 2025, Alcon (including the parent company, if applicable) has an estimated market capitalization of $48.62 B USD. This figure represents the total market value of its outstanding shares, including different share classes. Please note that market capitalization fluctuates based on market conditions, and the actual valuation may differ from the latest estimate.

Alcon global market capitalization ranking is approximately 428 as of May 4, 2025. This ranking is relative to all publicly traded companies worldwide and can fluctuate based on market dynamics and the performance of other companies. You can refer to our Global companies market cap ranking for the most up-to-date ranking.

Stock Detail

Country or region Switzerland
Founded 1945
IPO Date n/a
Employees 25,599
CEO David Endicott
Sector Healthcare
Industry Medical Instruments & Supplies
Address Chemin de Blandonnet 8, Vernier
Geneva, 1214
Switzerland